The study by Lang et al. suggested that METTL3-modified lncRNA PCAT6 promoted bone metastasis in prostate cancer via forming the IGF2BP2–IFG1R complex to stabilize IGF1R mRNA [37]. The gene discussed is IGF2BP2; the disease is prostate carcinoma.